Patient Engagement at eyeforpharma Barcelona

• Successfully implement the change needed to constantly improve productivity and leverage data to make smarter decisions for the patient journey

• Understand how true value can be translated from the patient rather than from the medicine or treatment regimen
• Understand how Merck has implemented a cross functional patient culture through it’s pharma sector

• Explore how Boehringer are using RWE to complement data from clinical trials with new levels of patient population understanding
• Enhance development efforts with easily accessible and communicable RWD platforms

Accelerate innovation by addressing patient and company challenges with design thinking

1. Learn how aspects of design thinking can be applied to generate solutions and solve even the most complex problems in the healthcare environment,
2. Think beyond digital, ensuring your organisation utilises new technology and ways of thinking to enhance the patient journey.
3. Envisage how other industries and companies have embedded design thinking within their organisation, which allows for continuous feedback and improvements to products and services

Curated and led by:

• Understand how Moderna Therapeutics has evolved as a truly digital biopharma organization and what this means for advancing drug candidates to clinical studies; increasing the agility of its research, development, and manufacturing processes; and achieveing results—such as personalized cancer vaccines—that would have been impossible even a few years ago.
• Lessons learnt from their journey and their vision for the future of the company and what this means for the future pharma business model

• Dive into Product and UX fundamentals! The tech gold rush has flooded conferences around the globe with promises of 'Blockchain-this' and 'AI-that', but organizations need to take a step back and lay strong foundations in order for these new technologies to truly provide incremental value.
• Help your business grow with new solutions and software that physicians will actually use. We, as life-science stakeholders, need to provide solutions to physicians' authentic, underserved needs – and we need to do so in a way that respects their time and native workflow.
• Delve into the 5 most important tenets of Product and User Experience design; the low-tech, tried-and-true tactics that engage an audience and lead to meaningful ROI.

• Understand how Pharma must offer services beyond-the-pill to deliver improvements in healthcare outcomes and meet the demands of Value Based Care
• Delve into the new normal of Medicine-as-a-Service and see how it has been rapidly evolving
• How Medicine-as-a-Service addresses the challenges that Pharma is facing including: Digital Innovation, RWE, Patient Centricity and much more.

• How do we simplify the process of prosective patient data capture for patients as they participate in post-approval research
• The role of technology – particularly advancing consumer technologies – in improving patient engagement during post-approval research

1. Deliver, prove and maximise ROI on your digital spend
2. Manage new suppliers and models in innovative tech
3. Accelerate global to local market impact with partners
4. Procurement as the digital transformation catalyst

Roundtable facilitators include:

• Filiz Saka Crockford, Commercial Procurement Category Lead Takeda
• Robert Zimmer, Global Category Manager, Digital Marketing, Novartis

• Understanding the real-world patient journey and response to treatment through remote patient monitoring
• Emphasising the importance of providing good quality data to pharmaceutical partner
• Identifying emerging trends within digital medicine and Medopad’s approach to navigating this space

• Fast-track a new paradigm for your sales reps and MSLs
• Define the balance of responsibilities and objectives throughout your whole field team

• Discuss feasible outcomes of patient engagement in medicine development
• What are relevant indicators to evaluate whether this outcome can be reached

• Discuss the changing needs for value assessment as levels of effectiveness increase
• How to foster more transparent partnership with government bodies

• Case Study: Explore how phase II of the IMI GetReal programme is developing industry-wide standards and methodologies to accelerate adoption of RWE
• Discuss how to incorporate RWE into the traditional R&D framework and tools available now to enhance operational efforts

• Discuss how the current partnership model is flawed and why we need to be partnering for new kinds of value
• Find out how the leading organizations are partnering by focusing on the friction and pain points of care, and building value alliances with key stakeholders

• Hear how LEO Innovation Lab ensure agility and how they can continuously drive innovation
• Find out how they use patient insights to leverage innovative new solutions in AI, assistant tools and machine learning.

• Focusing on patient outcomes when designing ‘pharma plus digital’ products
• Building a patient focused cross-functional agile team to launch a product

• Enhancing patient care leveraging DigitalTransforming scientific exchange, medical education and other Medical Affairs activities
• Establishing a new culture fit for future

• How to move beyond clinical measures and successfully capture what truly matters to patients to secure access

• Understand how AI can support the shift from reactive ""sickcare"" to the delivery of more people-centric, proactive health management and care
• Learn how AI-enabled tools will empower the individual to more effectively manage their health
• Preview how AI can support the earlier identification, prevention and management of chronic and rare disease.

• Amplify the value of your congress campaigns with innovative digital content and communications
• Use relevant, real-time content to engage with your key customers and stakeholders to improve their congress experience

• RPA is empowering business users to make transformational change without the cost and complexity associated with technology-led projects
• Imagine how highly-efficient Digital Workers collaborating seamlessly with humans could improve outcomes for your technicians, clinicians, managers, and patients
• Understand how you can leverage this Intelligent Automation, the combined power of enterprise RPA and class-leading artificial intelligence, to enhance business and clinical processes

• Design effective patient programs through personalized behavioural triggers
• Apply predictive analytics to create patient segments
• Build the infrastructure for an RWE strategy capable of informing tailored programs at scale

• The Patient empowerment evolution is changing Pharma companies’ Go to Market model led by Williams Lea Tag
• Boost HCP multi-channel communication with improved AI application led by antwerpes

More to be released soon

• Establish an Omni-channel customer view, understand customer decision journeys
• Observe customer behaviors and gather insights over short campaign iterations

• Obtain senior-level support for patient initiatives by linking efforts to outcomes

• Bring it home: use local affiliates to feed into international RWE and access planning
• Compare and contrast the range of HTA evidence hierarchies across Europe

• Creating inclusion across country, language, culture and ethnic barriers – the evolution of patient story telling
• How to improve ethnic representation in clinical trials
• Discuss best and worst case examples of pharma-patient group collaboration
• Disjointed relationship between pharma and med-tech and impact on patient lives
• An in-depth look at the efforts made in pain management and how we can better create access to physical therapies
• The changing space of patient advocacy/organisation corporate responsibility (CR) as influence, regulation and onlookers increase
• Building an experience-based framework to accelerate the growth/improve chances of success for start-up patient groups and organisations
• It’s raining digital applications – increase use through more targeted collaborative effort, driven by patient need

• Understand that the prevention and management of chronic diseases should focus not only on symptomatic patients but on individuals that do not yet have symptoms.
• Discuss how this disease-prevention strategy profoundly impacts clinical development, marketing and distribution of products, and new payor models.
• Appreciate how digital strategies that affect an individual’s behaviour towards lifestyle choices, can enhance adherence to treatment and positively affect clinical outcome

• Separate hype from reality, understand the trends in cognitive automation and how to apply this to your organization
• Hear how Pharma and Medtech are gaining maximum results and adapting their strategy with the market changes

• Up to 50% of Clinical Trials are delayed due to patient recruitment issues.
• Unstructured text-based Medical Records hold around 85% of patients' clinical information.
• Discover how IOMED helps you leverage the power of detailed patient data to speed up patient recruitment.

• Hear how AbbVie is collaborating with experts from outside the health industry in a bold preventative health move. By putting open-data at the forefront, AbbVie will explore the value of leveraging real-life, data-driven insights to further understand complex human behaviour, in order to ultimately help build a more sustainable NHS.

• Understand how Daichii-Sankyo’s holistic approach to customer centricity changes the role of their CFRs
• Hear about how 3 different projects influence the thinking and acting of sales rep already today
  • NPS targeting towards HCPs
  • Kiku targeting CFRs
  • www.mycancertherapy.eu targeting patients

• Use RWE to define clinical trial endpoints and meet Market Access goals in rare diseases
• Understand the multiple channels and high quality data sources available and usable

• Explore how to implement appropriate outcomes-based pricing models to match treatment innovation
• Understand the new needs of payers given the increasing levels of complexity in timelines and outcomes

• Everything you need to know about The Human Cell Atlas, an ambitious project, funded by the Chan-Zuckerberg Institute and others, to map every cell in the human body and how this could impact how drugs are developed
• Learn how the single revolution is rewriting our understanding of a human disease ranging from cancer to inflammatory conditions

• Change your perspective. Engage with patients as the key decision makers they’re becoming, and empower them to make educated decisions about their own health.
• Go deep to understand the patient journey and core customer needs. Do it well, and the insights can reveal hidden value pools, and possibly force you to change your company strategy
• Meet the needs of your customers by applying relevant digital tools. Implement by applying a start-up way of working, and it will be rocket fuel for your strategy.

• Hear how LEO Pharma is hacking their way into better HCP engagement, the results and challenges
• Understand not only the challenges of building the function and the business case for digital marketing

• Discuss pharma’s role in ensuring patient access and care are optimised for newly approved treatments
• Explore NICE’s new initiative enhancing the clinical/patient guidance for treatment at the point of approval

• See how the #PersonBeforePatient initiative is changing societies perception of what health means
• What does this mean to both patients and pharma beyond current therapeutic realities

• Blockchain is about more than cryptocurrencies – it enables multiple parties to jointly collaborate and transact in near real-time
• Records in the blockchain are encrypted and linked, addressing the heightened safety and privacy concerns that come with personalized care, patient registries & GDPR

1. Explore the evolution of pharma’s medical and commercial field force in a fast-changing external environment
2. In an hour-long interactive session hosted by field force leaders understand emerging capability requirements, measure effectiveness and ensure successful interactions

Roundtable facilitators include:

• Heather Moses, Head of Medical Affairs, Roche
• Dirk Abeel, Global Medical Sales Director, Reckitt Benckiser, Inc.
• Walter Sheloff, Customer Facing Medical Effectiveness Head - Europe, Pfizer
• Ingrid Marchal-Gerez, Senior Healthcare Solutions Leader, EMEA, Janssen

1. Design your internal RWE function: capability requirements, future proofing, ownership, investment needed
2. The impact of GDPR: discuss the impact existing and future privacy regulations/policies may
3. Meet RWE regulatory standards: which internal functions should take leadership/ensure relative quality in emerging area
4. Tapping Academic collaboration: explore the full potential of academic partnership for data generation
5. Changing the public perception: pharma’s role in educating and improving negative public attitudes to health data use
6. RWE in clinical trials: how best to bring big data into the development process
7. The pragmatic solution: why defining the right question for pragmatic studies is key
8. The future of data standardisation: explore existing and future European efforts to create a sustainable harmonised EU data ecosystem

• Within pharma, even more so than in other industries, there is a significant struggle to recover from the disillusionment of tough-to-adopt technologies or a lack of digital “quick wins”. Why is it so hard to reach that elusive slope of enlightenment on the hype cycle?
• What should we be more aware of when it comes to emerging technologies and how can we adjust our expectations?
• How do we do refocus our approach and efforts around digital transformation to build more momentum in our organizations and to better leverage our current digital investments?

• How to support launch strategy with Named Patient Programs (NPPs) and when it’s appropriate to consider this approach
• Learn How real-world data can be collected from NPPs to support launch strategy through case examples
• How to find best fit partners to support access/NPPs in Non-launch and/or Lower Priority Markets

• Learn how better to work with caregivers to collect data and insights on the patient journey
• Discuss the vital role collaboration with caregivers can play in communicating and working with patients
• How to incorporate carers into clinical trial recruitment processes to enhance timelines and accuracy of patient profiles

• Live demo of a global supply chain application that passes medication from manufacturers to suppliers to patients – this not only sets the stage to drive down out-of-stocks and counterfeits, but also the advent of personalized medicines
• Clinical study supply chains managed through blockchain make it possible to replace paper without compromising security or double-blind requirements
• Blockchain-based patient registries can provide safe and secure sandbox for AI, machine learning on aggregated data sets.

• Envision how an industry leading company has created a truly integrated omni-channel offering
• Equip different departments to begin the omni-channel transition and ensure the required capabilities are in place
• Tailor your marketing strategy to ensure alignment between various platforms to ensure a seamless, consistent and effortless user experience

• Explore the next steps in creating an environment capable of successfully enacting more outcomes-based agreements
• Strengthen stakeholder alignment with understanding of the groundwork capabilities needed for data needs

• Understand public perception concerns around data security, privacy and use preventing cloud adoption and larger scale data sharing
• Explore communication approaches and technical solutions to solve perception issues
• Discuss GDPR’s impact on industry data use and public concerns one year on

The Genomic Medicine Future: How to balance industry requirements with other key stakeholder groups who also have a critical role to play in preparing healthcare systems

• Hear a definition and key characteristics of population genomics programmes
• See examples from across EMEA – including operational features
• Understand what the industry requirements are
• Leave with an understanding of “What works well?” and “even better if …” from a leading expert in population genomics programmes

• Look into the future state of genomic data sharing and security as new technological advancements at the intersection of healthcare and information technology are developed.
• Describe how blockchain technology can enable genomic data creation, ensure its security, and allow for its sharing
• Discuss the future state of genomic research, genomic data security, genomic data standardization and data sharing between individuals and companies as whole genome sequencing costs continue to decrease.

• Uncover how can patient-centered know-how apply internally to design care interventions and programs for employees.
• Learn more about counselling as critical enabler of chronic disease recovery at work
• Get insights about “Cancer & Work: act together” program, that has applied counselling at scale at Sanofi France

• Driving business change based on local business cases rather than a one-size-fits-all – with results
• Practical applications of AI and automation to drive local business value
• Working with all levels – from General Managers to Marketers - to change the ways of working
• The hidden roadblocks and time saps in a true digital transformation

• Gain a more complete understanding of population health through enhanced partnership with young patients and carers
• Learn what new communication channels, approaches and capabilities will be necessary to overcome current industry lacking

• How the smartest companies are able to go beyond empowerment, beyond advocacy and work with patients for sustained access in a virtuous circle
• Why your goal must be to have the most comprehensive patient insights if you are ever going to gain trusted partner status

• itness how a shared commitment to address non-adherence in mental illness has created an edible, microscopic communication platform, approved by the FDA
• How the connection of hardware (as a medicine) and software has resulted in new product categories with a range of capabilities